Literature DB >> 11673163

Multimodality MR imaging depiction of hemodynamic changes and cerebral ischemia in subarachnoid hemorrhage.

P D Griffiths1, I D Wilkinson, P Mitchell, M C Patel, M N Paley, C A Romanowski, T Powell, T J Hodgson, N Hoggard, D Jellinek.   

Abstract

BACKGROUND AND
PURPOSE: Subarachnoid hemorrhage (SAH) is a common and serious neurologic emergent condition. We tested the hypothesis that multimodality MR imaging depicts changes in cerebral blood flow SAH, before any surgical or endovascular intervention, and that the frequency of these changes increases with time after ictus.
METHODS: We prospectively examined 37 patients with suspected SAH and three with symptoms of acute stroke but who subsequently had SAH. Routine CT and multimodality MR imaging were performed within 18 h of presentation. Standard MR imaging, diffusion-weighted MR imaging, time-of-flight MR angiography, and dynamic first-pass gadolinium-enhanced MR perfusion imaging were performed. Images were reviewed for abnormalities in cerebral blood flow, ischemia, and infarction. Nine patients did not have SAH at CT and CSF investigations. Of 31 patients with proved SAH, 13 were examined during the acute stage (within 4 d of ictus) and 18, during the subacute stage (4-14 d after ictus).
RESULTS: MR imaging showed alteration in cerebral blood flow parameters in 16 of 31 patients before surgery or endovascular treatment. The frequency of blood flow changes and associated complications increased with worsening clinical grade and increasing time after ictus.
CONCLUSION: Multimodality MR imaging provides information not available from CT in patients with SAH. MR imaging shows oligemic and ischemic areas in SAH before surgery or endovascular treatment. MR imaging is a simple noninvasive method of assessing cerebral blood flow and its complications in SAH. It can be performed in a clinical environment.

Entities:  

Mesh:

Year:  2001        PMID: 11673163      PMCID: PMC7974435     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  20 in total

1.  Acute subarachnoid haemorrhage: detection with magnetic resonance imaging.

Authors:  H Chrysikopoulos; N Papanikolaou; J Pappas; A Papandreou; A Roussakis; J Vassilouthis; J Andreou
Journal:  Br J Radiol       Date:  1996-07       Impact factor: 3.039

Review 2.  The diagnosis of subarachnoid haemorrhage.

Authors:  M Vermeulen; J van Gijn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-05       Impact factor: 10.154

3.  The relationship of blood velocity as measured by transcranial doppler ultrasonography to cerebral blood flow as determined by stable xenon computed tomographic studies after aneurysmal subarachnoid hemorrhage.

Authors:  B L Clyde; D K Resnick; H Yonas; H A Smith; A M Kaufmann
Journal:  Neurosurgery       Date:  1996-05       Impact factor: 4.654

4.  MR diagnosis of subacute and chronic subarachnoid hemorrhage: comparison with CT.

Authors:  T Ogawa; A Inugami; H Fujita; J Hatazawa; E Shimosegawa; K Noguchi; T Okudera; I Kanno; K Uemura; A Suzuki
Journal:  AJR Am J Roentgenol       Date:  1995-11       Impact factor: 3.959

5.  Isotropic diffusion-weighted and spiral-navigated interleaved EPI for routine imaging of acute stroke.

Authors:  K Butts; J Pauly; A de Crespigny; M Moseley
Journal:  Magn Reson Med       Date:  1997-11       Impact factor: 4.668

6.  Acute subarachnoid hemorrhage: MR imaging with fluid-attenuated inversion recovery pulse sequences.

Authors:  K Noguchi; T Ogawa; A Inugami; H Toyoshima; S Sugawara; J Hatazawa; H Fujita; E Shimosegawa; I Kanno; T Okudera
Journal:  Radiology       Date:  1995-09       Impact factor: 11.105

7.  Acute cerebral blood flow response to dopamine-induced hypertension after subarachnoid hemorrhage.

Authors:  J M Darby; H Yonas; E C Marks; S Durham; R W Snyder; E M Nemoto
Journal:  J Neurosurg       Date:  1994-05       Impact factor: 5.115

8.  Assessment of the value of MR imaging for examining patients with angiographically negative subarachnoid hemorrhage.

Authors:  J M Rogg; S Smeaton; C Doberstein; J H Goldstein; G A Tung; R A Haas
Journal:  AJR Am J Roentgenol       Date:  1999-01       Impact factor: 3.959

9.  Single photon emission computed tomography in patients with acute hydrocephalus or with cerebral ischaemia after subarachnoid haemorrhage.

Authors:  D Hasan; J van Peski; I Loeve; E P Krenning; M Vermeulen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-06       Impact factor: 10.154

10.  Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning.

Authors:  C M Fisher; J P Kistler; J M Davis
Journal:  Neurosurgery       Date:  1980-01       Impact factor: 4.654

View more
  6 in total

Review 1.  Spectrophotometry for cerebrospinal fluid pigment analysis.

Authors:  Axel Petzold; Lindsay T Sharpe; Geoffrey Keir
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

Review 2.  Intracranial hemorrhage: the role of magnetic resonance imaging.

Authors:  Peter D Schellinger; Jochen B Fiebach
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

3.  Comparison of cerebral perfusion in perimesencephalic subarachnoid hemorrhage and aneurysmal subarachnoid hemorrhage.

Authors:  Isabel Fragata; Nuno Canto-Moreira; Patrícia Canhão
Journal:  Neuroradiology       Date:  2018-03-09       Impact factor: 2.804

4.  MR imaging of recent non-traumatic intracranial hemorrhage: early experience at 3 T.

Authors:  Paul D Griffiths; Iain D Wilkinson
Journal:  Neuroradiology       Date:  2006-02-18       Impact factor: 2.804

5.  Advanced imaging modalities in the detection of cerebral vasospasm.

Authors:  Jena N Mills; Vivek Mehta; Jonathan Russin; Arun P Amar; Anandh Rajamohan; William J Mack
Journal:  Neurol Res Int       Date:  2013-02-06

6.  An experimental rabbit model of symptomatic cerebral vasospasm with in vivo neuroimaging assessment and ex vivo histological validation.

Authors:  Yunchang Mo; Luping Huang; Linbi Chen; Michael Veronesi; Yiyi Shi; Sijia Chen; Linli Peng; Leping Zhou; Yonglin Pu; Junlu Wang
Journal:  Exp Ther Med       Date:  2018-01-04       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.